There are three conferences being attended by Raptor Pharmaceutical in the next week or so. Is anybody able to comment on whether there will be news or updates on the current trials underway and their progress? Any opinions would be welcome. The stock is moving up as if something is being anticipated next week.
Just announced results for HD study. 34% reduction in disease progression! Significant improvement in total motor score on a long term test. Good safety profile. Investigators in France want this drug ASAP for those receiving it in trials. Raptor will meet with Government agencies to discuss the next step toward approval for HD drug. Other pipelines for Nash disease and Leigh syndrome progressing well. Overall, very good news!